Markets:

Overview

News

Currencies

International

Treasuries

Cencora, Inc. Common Stock (NY:COR)

364.34 +5.09 (+1.42%)

Streaming Delayed Price Updated: 2:41 PM EST, Feb 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Cencora, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Breaking Down Cencora: 6 Analysts Share Their Views ↗

January 24, 2025

Via Benzinga

Jim Cramer: Lemonade Is 'Up Too Much,' This Health Care Stock Can Go Lower ↗

January 08, 2025

JMP Securities analyst Ronald Josey maintained Lemonade with a Market Outperform and raised the price target from $40 to $60.

Via Benzinga

Cencora Announces Date and Time for First Quarter Fiscal 2025 Earnings Release

January 08, 2025

From Cencora

Via Business Wire

Cencora Completes Acquisition of Retina Consultants of America

January 02, 2025

From Cencora

Via Business Wire

Looking Into Cencora's Recent Short Interest ↗

January 02, 2025

Via Benzinga

Here's How Much You Would Have Made Owning Cencora Stock In The Last 10 Years ↗

December 30, 2024

Via Benzinga

If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today ↗

December 17, 2024

Via Benzinga

(COR) - Analyzing Cencora's Short Interest ↗

December 11, 2024

Via Benzinga

Cencora Closes $1.8 Billion Senior Notes Offering

December 09, 2024

From Cencora

Via Business Wire

$100 Invested In Cencora 5 Years Ago Would Be Worth This Much Today ↗

December 09, 2024

Via Benzinga

Cencora Prices $500 Million 4.625% Senior Notes Due 2027, $600 Million 4.850% Senior Notes Due 2029 and $700 Million 5.150% Senior Notes Due 2035

December 02, 2024

From Cencora

Via Business Wire

Looking Into Cencora's Recent Short Interest ↗

November 21, 2024

Via Benzinga

McKesson Stock Gets A RS Rating Lift To 75 ↗

November 13, 2024

The Relative Strength (RS) Rating for McKesson stock jumped into a new percentile Wednesday, as it got a lift from 70 to 75.

Via Investor's Business Daily

Cardinal Health Stock Sees IBD RS Rating Improve To 71 ↗

November 08, 2024

In a welcome move, Cardinal Health stock saw its Relative Strength (RS) Rating rise from 65 to 71 on Friday.

Via Investor's Business Daily

Deep Dive Into Cencora Stock: Analyst Perspectives (6 Ratings) ↗

November 07, 2024

Via Benzinga

Trump's Win Sends Indices To Record Highs; Financials, Small Caps Surge, Bitcoin Tops $75,000: What's Driving Markets Wednesday? ↗

November 06, 2024

An “everything rally” powered Wall Street on Wednesday after the 2024 election results, with Donald Trump emerging as the clear presidential winner.

Via Benzinga

Topics Government

Cencora Acquires Retina Care Practice Network For $4.6 Billion, Boosts Dividend On Better Than Expected Q4 Earnings ↗

November 06, 2024

Cencora will potentially pay up to $500 million in aggregate contingent consideration in fiscal years 2027 and 2028.

Via Benzinga

Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results

November 06, 2024

From Cencora

Via Business Wire

If You Invested $100 In This Stock 5 Years Ago, You Would Have $300 Today ↗

October 24, 2024

Via Benzinga

$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,700 Today ↗

October 09, 2024

Via Benzinga

Analyst Scoreboard: 6 Ratings For Cencora ↗

October 07, 2024

Via Benzinga

Cencora Advances Specialty Leadership Through Acquisition of Retina Consultants of America

November 06, 2024

From Cencora

Via Business Wire

Cencora Expands Enterprise Leadership Team with Two Senior Appointments

November 04, 2024

From Cencora

Via Business Wire

Walgreens Stock Rally: 4 Reasons WBA Could Be a Strong Buy

October 22, 2024

Walgreens Boots Alliance (WBA) is down 60% from its 52-week high, but improving earnings, cost cuts, and a 9.27% dividend yield signal potential recovery.

Via MarketBeat

Cencora Announces Date and Time for Fourth Quarter Fiscal 2024 Earnings Release

October 01, 2024

From Cencora

Via Business Wire

Here's How Much $1000 Invested In Cencora 5 Years Ago Would Be Worth Today ↗

September 23, 2024

Via Benzinga

Here's How Much You Would Have Made Owning Cencora Stock In The Last 5 Years ↗

September 09, 2024

Via Benzinga

Novo Nordisk, Chewy And FedEx Are Among Top 10 Large Cap Losers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio? ↗

September 22, 2024

10 large-cap stocks worst performers in last week: SMMT -23.61%, KSPI -21.66%, BMRN -16.74%, RIVN -13.26%, FDX -11.08%, BNTX -9.01%, AJG -7.17%, CHWY -6.97%, NVO -6.93%, MUSA -6.90%

Via Benzinga

Deep Dive Into Cencora Stock: Analyst Perspectives (6 Ratings) ↗

September 06, 2024

Via Benzinga

Why Walgreens Boots Alliance Fell Another 22% in August ↗

September 05, 2024

The retail pharmacy giant faces ever-mounting headwinds.

Via The Motley Fool

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Cencora, Inc. Common Stock (NY:COR)

All News about Cencora, Inc. Common Stock

Starting at $3.75/week.

Subscribe Today